JP2008510493A

JP2008510493A - 腫瘍細胞の形質導入強化のための線維改変アデノウイルスベクター

腫瘍細胞の形質導入強化のための線維改変アデノウイルスベクター Download PDF

Info

Publication number: JP2008510493A
Authority: JP; Japan
Prior art keywords: cell; adenovirus; cells; tre; tumor
Prior art date: 2004-08-25
Legal status : Withdrawn

Application number

JP2007530107A

Other languages

English (en)

Japanese (ja)

Other versions

JP2008510493A5 (enExample

Inventor

セシダーレディーポリス，

シャンティガネシュ，

デチャオユ，

Original Assignee

セルジェネシスインコーポレイテッド

Priority date

2004-08-25

Filing date

2005-08-25

Publication date

2008-04-10

2005-08-25 Application filed by セルジェネシスインコーポレイテッド filed Critical セルジェネシスインコーポレイテッド

2008-04-10 Publication of JP2008510493A publication Critical patent/JP2008510493A/ja

2008-09-11 Publication of JP2008510493A5 publication Critical patent/JP2008510493A5/ja

Status Withdrawn legal-status Critical Current

Links

239000013598 vector Substances 0.000 title claims abstract description 253
210000004881 tumor cell Anatomy 0.000 title claims abstract description 239
241000701161 unidentified adenovirus Species 0.000 title claims abstract description 166
238000010361 transduction Methods 0.000 title description 41
230000026683 transduction Effects 0.000 title description 41
238000000034 method Methods 0.000 claims abstract description 108
101710145505 Fiber protein Proteins 0.000 claims abstract description 70
150000007523 nucleic acids Chemical class 0.000 claims abstract description 53
102000039446 nucleic acids Human genes 0.000 claims abstract description 39
108020004707 nucleic acids Proteins 0.000 claims abstract description 39
101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 claims abstract description 20
102100039373 Membrane cofactor protein Human genes 0.000 claims abstract description 20
230000002463 transducing effect Effects 0.000 claims abstract description 7
210000004027 cell Anatomy 0.000 claims description 444
108700029229 Transcriptional Regulatory Elements Proteins 0.000 claims description 141
108091026890 Coding region Proteins 0.000 claims description 82
230000010076 replication Effects 0.000 claims description 58
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 57
150000001413 amino acids Chemical class 0.000 claims description 50
230000001105 regulatory effect Effects 0.000 claims description 33
238000012217 deletion Methods 0.000 claims description 32
230000037430 deletion Effects 0.000 claims description 32
210000001519 tissue Anatomy 0.000 claims description 29
241000124008 Mammalia Species 0.000 claims description 25
230000000735 allogeneic effect Effects 0.000 claims description 25
238000000338 in vitro Methods 0.000 claims description 19
208000014829 head and neck neoplasm Diseases 0.000 claims description 15
238000001727 in vivo Methods 0.000 claims description 14
208000008839 Kidney Neoplasms Diseases 0.000 claims description 11
208000020816 lung neoplasm Diseases 0.000 claims description 11
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 9
101710138647 Protein tyrosine phosphatase type IVA 3 Proteins 0.000 claims description 9
208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 7
102100024601 Protein tyrosine phosphatase type IVA 3 Human genes 0.000 claims description 6
108010017842 Telomerase Proteins 0.000 claims description 6
208000037841 lung tumor Diseases 0.000 claims description 5
108010042121 probasin Proteins 0.000 claims description 5
208000023958 prostate neoplasm Diseases 0.000 claims description 5
101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims description 3
108010051081 dopachrome isomerase Proteins 0.000 claims description 3
101710201734 E3 protein Proteins 0.000 claims description 2
102100031413 L-dopachrome tautomerase Human genes 0.000 claims description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims description 2
102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims description 2
108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims description 2
230000000415 inactivating effect Effects 0.000 claims description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 3
108010027410 Adenovirus E3 Proteins Proteins 0.000 claims 2
101100228942 Mus musculus Gldn gene Proteins 0.000 claims 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 1
108700026758 Adenovirus hexon capsid Proteins 0.000 abstract description 10
206010028980 Neoplasm Diseases 0.000 description 194
108090000623 proteins and genes Proteins 0.000 description 179
108700019146 Transgenes Proteins 0.000 description 96
241001135569 Human adenovirus 5 Species 0.000 description 95
201000011510 cancer Diseases 0.000 description 85
239000000835 fiber Substances 0.000 description 69
102000004169 proteins and genes Human genes 0.000 description 69
235000018102 proteins Nutrition 0.000 description 65
241000700605 Viruses Species 0.000 description 61
102000004127 Cytokines Human genes 0.000 description 57
108090000695 Cytokines Proteins 0.000 description 57
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 55
230000014509 gene expression Effects 0.000 description 54
238000003776 cleavage reaction Methods 0.000 description 48
239000002245 particle Substances 0.000 description 48
230000007017 scission Effects 0.000 description 48
108020004414 DNA Proteins 0.000 description 44
230000028993 immune response Effects 0.000 description 39
239000012634 fragment Substances 0.000 description 38
108091028043 Nucleic acid sequence Proteins 0.000 description 37
239000000203 mixture Substances 0.000 description 37
239000013612 plasmid Substances 0.000 description 37
239000000427 antigen Substances 0.000 description 36
108091007433 antigens Proteins 0.000 description 36
102000036639 antigens Human genes 0.000 description 36
230000000981 bystander Effects 0.000 description 33
102000040430 polynucleotide Human genes 0.000 description 31
108091033319 polynucleotide Proteins 0.000 description 31
239000002157 polynucleotide Substances 0.000 description 31
238000012545 processing Methods 0.000 description 31
239000002773 nucleotide Substances 0.000 description 30
125000003729 nucleotide group Chemical group 0.000 description 30
238000013518 transcription Methods 0.000 description 30
230000035897 transcription Effects 0.000 description 30
101150075174 E1B gene Proteins 0.000 description 28
239000003623 enhancer Substances 0.000 description 28
108090000765 processed proteins & peptides Proteins 0.000 description 27
238000011282 treatment Methods 0.000 description 27
229940024606 amino acid Drugs 0.000 description 26
235000001014 amino acid Nutrition 0.000 description 25
201000001441 melanoma Diseases 0.000 description 25
238000003752 polymerase chain reaction Methods 0.000 description 23
230000003612 virological effect Effects 0.000 description 23
239000013603 viral vector Substances 0.000 description 22
101710197337 Adenovirus death protein Proteins 0.000 description 21
102000004196 processed proteins & peptides Human genes 0.000 description 21
230000001225 therapeutic effect Effects 0.000 description 21
229920001184 polypeptide Polymers 0.000 description 20
239000005090 green fluorescent protein Substances 0.000 description 18
239000000047 product Substances 0.000 description 18
230000000694 effects Effects 0.000 description 17
230000006870 function Effects 0.000 description 16
239000003446 ligand Substances 0.000 description 16
208000015181 infectious disease Diseases 0.000 description 15
102000040945 Transcription factor Human genes 0.000 description 14
108091023040 Transcription factor Proteins 0.000 description 14
102000005962 receptors Human genes 0.000 description 14
108020003175 receptors Proteins 0.000 description 14
108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 13
108091081024 Start codon Proteins 0.000 description 13
102000046157 human CSF2 Human genes 0.000 description 13
238000004519 manufacturing process Methods 0.000 description 13
230000004048 modification Effects 0.000 description 13
238000012986 modification Methods 0.000 description 13
230000000174 oncolytic effect Effects 0.000 description 13
238000013519 translation Methods 0.000 description 13
238000011144 upstream manufacturing Methods 0.000 description 13
108700018351 Major Histocompatibility Complex Proteins 0.000 description 12
206010060862 Prostate cancer Diseases 0.000 description 12
208000000236 Prostatic Neoplasms Diseases 0.000 description 12
201000010536 head and neck cancer Diseases 0.000 description 12
230000002062 proliferating effect Effects 0.000 description 12
241000588724 Escherichia coli Species 0.000 description 11
108700026244 Open Reading Frames Proteins 0.000 description 11
230000012010 growth Effects 0.000 description 11
210000005260 human cell Anatomy 0.000 description 11
210000004962 mammalian cell Anatomy 0.000 description 11
230000009885 systemic effect Effects 0.000 description 11
230000002103 transcriptional effect Effects 0.000 description 11
229960005486 vaccine Drugs 0.000 description 11
108091003079 Bovine Serum Albumin Proteins 0.000 description 10
102000004190 Enzymes Human genes 0.000 description 10
108090000790 Enzymes Proteins 0.000 description 10
229940032072 GVAX vaccine Drugs 0.000 description 10
-1 PEG Chemical class 0.000 description 10
230000001413 cellular effect Effects 0.000 description 10
230000003013 cytotoxicity Effects 0.000 description 10
231100000135 cytotoxicity Toxicity 0.000 description 10
229940088598 enzyme Drugs 0.000 description 10
239000001963 growth medium Substances 0.000 description 10
210000002752 melanocyte Anatomy 0.000 description 10
125000000539 amino acid group Chemical group 0.000 description 9
230000008901 benefit Effects 0.000 description 9
230000001472 cytotoxic effect Effects 0.000 description 9
239000012091 fetal bovine serum Substances 0.000 description 9
210000000987 immune system Anatomy 0.000 description 9
239000002953 phosphate buffered saline Substances 0.000 description 9
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 9
108091008146 restriction endonucleases Proteins 0.000 description 9
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 9
102100032187 Androgen receptor Human genes 0.000 description 8
206010038389 Renal cancer Diseases 0.000 description 8
108010080146 androgen receptors Proteins 0.000 description 8
230000002950 deficient Effects 0.000 description 8
230000006801 homologous recombination Effects 0.000 description 8
238000002744 homologous recombination Methods 0.000 description 8
201000010982 kidney cancer Diseases 0.000 description 8
201000007270 liver cancer Diseases 0.000 description 8
208000014018 liver neoplasm Diseases 0.000 description 8
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 7
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
102000013529 alpha-Fetoproteins Human genes 0.000 description 7
108010026331 alpha-Fetoproteins Proteins 0.000 description 7
238000003556 assay Methods 0.000 description 7
230000000295 complement effect Effects 0.000 description 7
239000002299 complementary DNA Substances 0.000 description 7
201000010099 disease Diseases 0.000 description 7
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
230000001976 improved effect Effects 0.000 description 7
238000002347 injection Methods 0.000 description 7
239000007924 injection Substances 0.000 description 7
108020004999 messenger RNA Proteins 0.000 description 7
210000005170 neoplastic cell Anatomy 0.000 description 7
238000006467 substitution reaction Methods 0.000 description 7
239000000725 suspension Substances 0.000 description 7
102100026189 Beta-galactosidase Human genes 0.000 description 6
108010006303 Carboxypeptidases Proteins 0.000 description 6
102000005367 Carboxypeptidases Human genes 0.000 description 6
108020004705 Codon Proteins 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
102000004961 Furin Human genes 0.000 description 6
108090001126 Furin Proteins 0.000 description 6
101710177565 Gliomedin Proteins 0.000 description 6
206010058467 Lung neoplasm malignant Diseases 0.000 description 6
206010061902 Pancreatic neoplasm Diseases 0.000 description 6
102000004504 Urokinase Plasminogen Activator Receptors Human genes 0.000 description 6
108010042352 Urokinase Plasminogen Activator Receptors Proteins 0.000 description 6
230000002159 abnormal effect Effects 0.000 description 6
108010005774 beta-Galactosidase Proteins 0.000 description 6
239000006285 cell suspension Substances 0.000 description 6
230000029087 digestion Effects 0.000 description 6
230000002068 genetic effect Effects 0.000 description 6
239000003112 inhibitor Substances 0.000 description 6
201000005202 lung cancer Diseases 0.000 description 6
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 6
208000002154 non-small cell lung carcinoma Diseases 0.000 description 6
201000002528 pancreatic cancer Diseases 0.000 description 6
208000008443 pancreatic carcinoma Diseases 0.000 description 6
208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 6
210000002845 virion Anatomy 0.000 description 6
HXNBAOLVPAWYLT-NVNXTCNLSA-N (5z)-5-[[5-bromo-2-[(2-bromophenyl)methoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound S\1C(=S)NC(=O)C/1=C/C1=CC(Br)=CC=C1OCC1=CC=CC=C1Br HXNBAOLVPAWYLT-NVNXTCNLSA-N 0.000 description 5
108090000565 Capsid Proteins Proteins 0.000 description 5
201000009030 Carcinoma Diseases 0.000 description 5
102100023321 Ceruloplasmin Human genes 0.000 description 5
102000029816 Collagenase Human genes 0.000 description 5
108060005980 Collagenase Proteins 0.000 description 5
239000012981 Hank's balanced salt solution Substances 0.000 description 5
108010002350 Interleukin-2 Proteins 0.000 description 5
102000000588 Interleukin-2 Human genes 0.000 description 5
108090000542 Lymphotoxin-alpha Proteins 0.000 description 5
102100034256 Mucin-1 Human genes 0.000 description 5
206010033128 Ovarian cancer Diseases 0.000 description 5
206010061535 Ovarian neoplasm Diseases 0.000 description 5
108010072866 Prostate-Specific Antigen Proteins 0.000 description 5
102100038358 Prostate-specific antigen Human genes 0.000 description 5
210000001744 T-lymphocyte Anatomy 0.000 description 5
108700009124 Transcription Initiation Site Proteins 0.000 description 5
108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 5
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 5
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 5
238000013459 approach Methods 0.000 description 5
230000033228 biological regulation Effects 0.000 description 5
229940030156 cell vaccine Drugs 0.000 description 5
229960002424 collagenase Drugs 0.000 description 5
238000009472 formulation Methods 0.000 description 5
238000001415 gene therapy Methods 0.000 description 5
210000003958 hematopoietic stem cell Anatomy 0.000 description 5
239000005556 hormone Substances 0.000 description 5
229940088597 hormone Drugs 0.000 description 5
239000000411 inducer Substances 0.000 description 5
230000002458 infectious effect Effects 0.000 description 5
210000004072 lung Anatomy 0.000 description 5
210000002540 macrophage Anatomy 0.000 description 5
239000003550 marker Substances 0.000 description 5
230000003362 replicative effect Effects 0.000 description 5
210000003932 urinary bladder Anatomy 0.000 description 5
108010087905 Adenovirus E1B Proteins Proteins 0.000 description 4
206010005003 Bladder cancer Diseases 0.000 description 4
241000283690 Bos taurus Species 0.000 description 4
206010006187 Breast cancer Diseases 0.000 description 4
208000026310 Breast neoplasm Diseases 0.000 description 4
206010008342 Cervix carcinoma Diseases 0.000 description 4
206010009944 Colon cancer Diseases 0.000 description 4
206010055114 Colon cancer metastatic Diseases 0.000 description 4
108700039887 Essential Genes Proteins 0.000 description 4
241000282412 Homo Species 0.000 description 4
101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 description 4
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 4
102000004083 Lymphotoxin-alpha Human genes 0.000 description 4
108091054437 MHC class I family Proteins 0.000 description 4
108091027981 Response element Proteins 0.000 description 4
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
102100040247 Tumor necrosis factor Human genes 0.000 description 4
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 4
108700005077 Viral Genes Proteins 0.000 description 4
238000007792 addition Methods 0.000 description 4
239000005557 antagonist Substances 0.000 description 4
230000000259 anti-tumor effect Effects 0.000 description 4
210000000612 antigen-presenting cell Anatomy 0.000 description 4
230000000890 antigenic effect Effects 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
238000009709 capacitor discharge sintering Methods 0.000 description 4
201000010881 cervical cancer Diseases 0.000 description 4
238000010276 construction Methods 0.000 description 4
231100000433 cytotoxic Toxicity 0.000 description 4
230000007423 decrease Effects 0.000 description 4
230000002708 enhancing effect Effects 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
238000000684 flow cytometry Methods 0.000 description 4
230000006872 improvement Effects 0.000 description 4
230000001939 inductive effect Effects 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
239000002502 liposome Substances 0.000 description 4
210000005229 liver cell Anatomy 0.000 description 4
238000010369 molecular cloning Methods 0.000 description 4
230000035772 mutation Effects 0.000 description 4
238000004806 packaging method and process Methods 0.000 description 4
230000035790 physiological processes and functions Effects 0.000 description 4
210000002307 prostate Anatomy 0.000 description 4
210000005267 prostate cell Anatomy 0.000 description 4
230000006337 proteolytic cleavage Effects 0.000 description 4
230000003584 silencer Effects 0.000 description 4
238000007920 subcutaneous administration Methods 0.000 description 4
230000001629 suppression Effects 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
230000008685 targeting Effects 0.000 description 4
238000012360 testing method Methods 0.000 description 4
229940124597 therapeutic agent Drugs 0.000 description 4
230000001988 toxicity Effects 0.000 description 4
231100000419 toxicity Toxicity 0.000 description 4
238000012546 transfer Methods 0.000 description 4
201000005112 urinary bladder cancer Diseases 0.000 description 4
238000002255 vaccination Methods 0.000 description 4
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 3
IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 3
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 3
108010012236 Chemokines Proteins 0.000 description 3
102000019034 Chemokines Human genes 0.000 description 3
102000000311 Cytosine Deaminase Human genes 0.000 description 3
108010080611 Cytosine Deaminase Proteins 0.000 description 3
101100440985 Danio rerio crad gene Proteins 0.000 description 3
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
201000008808 Fibrosarcoma Diseases 0.000 description 3
208000032612 Glial tumor Diseases 0.000 description 3
206010018338 Glioma Diseases 0.000 description 3
102100039992 Gliomedin Human genes 0.000 description 3
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 3
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 3
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 3
101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 3
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 3
241000701124 Human adenovirus 35 Species 0.000 description 3
206010021143 Hypoxia Diseases 0.000 description 3
102000004388 Interleukin-4 Human genes 0.000 description 3
108090000978 Interleukin-4 Proteins 0.000 description 3
108090001005 Interleukin-6 Proteins 0.000 description 3
102000004889 Interleukin-6 Human genes 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
102000043129 MHC class I family Human genes 0.000 description 3
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 3
206010027476 Metastases Diseases 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
101100440987 Mus musculus Cracd gene Proteins 0.000 description 3
101100467905 Mus musculus Rdh16 gene Proteins 0.000 description 3
206010029260 Neuroblastoma Diseases 0.000 description 3
102000008299 Nitric Oxide Synthase Human genes 0.000 description 3
108010021487 Nitric Oxide Synthase Proteins 0.000 description 3
108091034057 RNA (poly(A)) Proteins 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
208000005718 Stomach Neoplasms Diseases 0.000 description 3
102000004338 Transferrin Human genes 0.000 description 3
108090000901 Transferrin Proteins 0.000 description 3
230000004913 activation Effects 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
230000004075 alteration Effects 0.000 description 3
239000003098 androgen Substances 0.000 description 3
230000000118 anti-neoplastic effect Effects 0.000 description 3
230000002238 attenuated effect Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
230000037396 body weight Effects 0.000 description 3
210000001185 bone marrow Anatomy 0.000 description 3
239000000872 buffer Substances 0.000 description 3
239000012830 cancer therapeutic Substances 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
230000030833 cell death Effects 0.000 description 3
230000032823 cell division Effects 0.000 description 3
238000002512 chemotherapy Methods 0.000 description 3
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 3
229960004316 cisplatin Drugs 0.000 description 3
238000010367 cloning Methods 0.000 description 3
208000029742 colonic neoplasm Diseases 0.000 description 3
230000001461 cytolytic effect Effects 0.000 description 3
230000000120 cytopathologic effect Effects 0.000 description 3
210000004443 dendritic cell Anatomy 0.000 description 3
239000003814 drug Substances 0.000 description 3
239000003937 drug carrier Substances 0.000 description 3
210000002889 endothelial cell Anatomy 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
206010017758 gastric cancer Diseases 0.000 description 3
239000003102 growth factor Substances 0.000 description 3
230000007954 hypoxia Effects 0.000 description 3
230000002519 immonomodulatory effect Effects 0.000 description 3
230000002163 immunogen Effects 0.000 description 3
108090000237 interleukin-24 Proteins 0.000 description 3
102000003898 interleukin-24 Human genes 0.000 description 3
230000003902 lesion Effects 0.000 description 3
210000001165 lymph node Anatomy 0.000 description 3
239000000463 material Substances 0.000 description 3
230000001404 mediated effect Effects 0.000 description 3
210000003716 mesoderm Anatomy 0.000 description 3
230000001613 neoplastic effect Effects 0.000 description 3
210000004882 non-tumor cell Anatomy 0.000 description 3
210000000496 pancreas Anatomy 0.000 description 3
230000001717 pathogenic effect Effects 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
230000001323 posttranslational effect Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000011002 quantification Methods 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
201000009410 rhabdomyosarcoma Diseases 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
235000002639 sodium chloride Nutrition 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
201000011549 stomach cancer Diseases 0.000 description 3
239000000126 substance Substances 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
208000001608 teratocarcinoma Diseases 0.000 description 3
239000003053 toxin Substances 0.000 description 3
231100000765 toxin Toxicity 0.000 description 3
108700012359 toxins Proteins 0.000 description 3
239000012581 transferrin Substances 0.000 description 3
230000009261 transgenic effect Effects 0.000 description 3
230000014621 translational initiation Effects 0.000 description 3
102000035160 transmembrane proteins Human genes 0.000 description 3
108091005703 transmembrane proteins Proteins 0.000 description 3
230000004614 tumor growth Effects 0.000 description 3
208000024719 uterine cervix neoplasm Diseases 0.000 description 3
CXURGFRDGROIKG-UHFFFAOYSA-N 3,3-bis(chloromethyl)oxetane Chemical group ClCC1(CCl)COC1 CXURGFRDGROIKG-UHFFFAOYSA-N 0.000 description 2
108020005029 5' Flanking Region Proteins 0.000 description 2
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 2
102000013918 Apolipoproteins E Human genes 0.000 description 2
108010025628 Apolipoproteins E Proteins 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
208000003174 Brain Neoplasms Diseases 0.000 description 2
102000000844 Cell Surface Receptors Human genes 0.000 description 2
108010001857 Cell Surface Receptors Proteins 0.000 description 2
102100031162 Collagen alpha-1(XVIII) chain Human genes 0.000 description 2
108091035707 Consensus sequence Proteins 0.000 description 2
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
201000003883 Cystic fibrosis Diseases 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
102100029588 Deoxycytidine kinase Human genes 0.000 description 2
108010033174 Deoxycytidine kinase Proteins 0.000 description 2
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
101150082674 E2 gene Proteins 0.000 description 2
241000710188 Encephalomyocarditis virus Species 0.000 description 2
108010079505 Endostatins Proteins 0.000 description 2
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
241000714188 Friend murine leukemia virus Species 0.000 description 2
108700012941 GNRH1 Proteins 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 2
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
208000009889 Herpes Simplex Diseases 0.000 description 2
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 2
108091006905 Human Serum Albumin Proteins 0.000 description 2
102000008100 Human Serum Albumin Human genes 0.000 description 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 2
102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 2
102000014429 Insulin-like growth factor Human genes 0.000 description 2
102100025390 Integrin beta-2 Human genes 0.000 description 2
102000000589 Interleukin-1 Human genes 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
102000003814 Interleukin-10 Human genes 0.000 description 2
108090000174 Interleukin-10 Proteins 0.000 description 2
102000013462 Interleukin-12 Human genes 0.000 description 2
108010065805 Interleukin-12 Proteins 0.000 description 2
108010002616 Interleukin-5 Proteins 0.000 description 2
102100039897 Interleukin-5 Human genes 0.000 description 2
108010002586 Interleukin-7 Proteins 0.000 description 2
102000000704 Interleukin-7 Human genes 0.000 description 2
102000015696 Interleukins Human genes 0.000 description 2
108010063738 Interleukins Proteins 0.000 description 2
229930182816 L-glutamine Natural products 0.000 description 2
108010001831 LDL receptors Proteins 0.000 description 2
102100032352 Leukemia inhibitory factor Human genes 0.000 description 2
108090000581 Leukemia inhibitory factor Proteins 0.000 description 2
102100024640 Low-density lipoprotein receptor Human genes 0.000 description 2
206010025323 Lymphomas Diseases 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
108091054438 MHC class II family Proteins 0.000 description 2
239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 2
108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 2
108010006035 Metalloproteases Proteins 0.000 description 2
102000005741 Metalloproteases Human genes 0.000 description 2
241000713869 Moloney murine leukemia virus Species 0.000 description 2
108010008707 Mucin-1 Proteins 0.000 description 2
208000034578 Multiple myelomas Diseases 0.000 description 2
241001529936 Murinae Species 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
241000699660 Mus musculus Species 0.000 description 2
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
108010025020 Nerve Growth Factor Proteins 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
206010035226 Plasma cell myeloma Diseases 0.000 description 2
108010039918 Polylysine Proteins 0.000 description 2
208000037062 Polyps Diseases 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
239000004365 Protease Substances 0.000 description 2
101710132082 Pyrimidine/purine nucleoside phosphorylase Proteins 0.000 description 2
239000012980 RPMI-1640 medium Substances 0.000 description 2
208000015634 Rectal Neoplasms Diseases 0.000 description 2
102000006382 Ribonucleases Human genes 0.000 description 2
108010083644 Ribonucleases Proteins 0.000 description 2
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine kinase Proteins 0.000 description 2
102100031372 Thymidine phosphorylase Human genes 0.000 description 2
101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 2
108090000631 Trypsin Proteins 0.000 description 2
102000004142 Trypsin Human genes 0.000 description 2
206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 2
108060008724 Tyrosinase Proteins 0.000 description 2
102000012349 Uroplakins Human genes 0.000 description 2
108010061861 Uroplakins Proteins 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
230000009471 action Effects 0.000 description 2
208000009956 adenocarcinoma Diseases 0.000 description 2
230000001772 anti-angiogenic effect Effects 0.000 description 2
230000001093 anti-cancer Effects 0.000 description 2
230000000692 anti-sense effect Effects 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
230000005975 antitumor immune response Effects 0.000 description 2
230000006907 apoptotic process Effects 0.000 description 2
210000003719 b-lymphocyte Anatomy 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
108700000707 bcl-2-Associated X Proteins 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
210000000481 breast Anatomy 0.000 description 2
229940022399 cancer vaccine Drugs 0.000 description 2
238000009566 cancer vaccine Methods 0.000 description 2
230000006037 cell lysis Effects 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
239000013553 cell monolayer Substances 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
210000001072 colon Anatomy 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
210000000448 cultured tumor cell Anatomy 0.000 description 2
YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
229960004397 cyclophosphamide Drugs 0.000 description 2
108010057085 cytokine receptors Proteins 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
229940127089 cytotoxic agent Drugs 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000034994 death Effects 0.000 description 2
238000000432 density-gradient centrifugation Methods 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000010494 dissociation reaction Methods 0.000 description 2
230000005593 dissociations Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
238000001976 enzyme digestion Methods 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 2
229960004413 flucytosine Drugs 0.000 description 2
229960002949 fluorouracil Drugs 0.000 description 2
230000004927 fusion Effects 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
230000009036 growth inhibition Effects 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
230000036541 health Effects 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
210000002865 immune cell Anatomy 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
238000001802 infusion Methods 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
108010044426 integrins Proteins 0.000 description 2
102000006495 integrins Human genes 0.000 description 2
229940047122 interleukins Drugs 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
239000007788 liquid Substances 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
230000003211 malignant effect Effects 0.000 description 2
239000002609 medium Substances 0.000 description 2
230000009401 metastasis Effects 0.000 description 2
238000011580 nude mouse model Methods 0.000 description 2
244000309459 oncolytic virus Species 0.000 description 2
210000001672 ovary Anatomy 0.000 description 2
230000003076 paracrine Effects 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
244000052769 pathogen Species 0.000 description 2
239000008188 pellet Substances 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
229920000656 polylysine Polymers 0.000 description 2
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
239000002243 precursor Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000001959 radiotherapy Methods 0.000 description 2
238000010188 recombinant method Methods 0.000 description 2
206010038038 rectal cancer Diseases 0.000 description 2
201000001275 rectum cancer Diseases 0.000 description 2
238000012552 review Methods 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
230000028043 self proteolysis Effects 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
239000000243 solution Substances 0.000 description 2
241000894007 species Species 0.000 description 2
201000011096 spinal cancer Diseases 0.000 description 2
208000014618 spinal cord cancer Diseases 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
238000007910 systemic administration Methods 0.000 description 2
238000011285 therapeutic regimen Methods 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
230000009466 transformation Effects 0.000 description 2
239000006163 transport media Substances 0.000 description 2
239000012588 trypsin Substances 0.000 description 2
229940030325 tumor cell vaccine Drugs 0.000 description 2
230000005951 type IV hypersensitivity Effects 0.000 description 2
208000027930 type IV hypersensitivity disease Diseases 0.000 description 2
108010014402 tyrosinase-related protein-1 Proteins 0.000 description 2
210000001635 urinary tract Anatomy 0.000 description 2
210000003741 urothelium Anatomy 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
ZXXTYLFVENEGIP-UHFFFAOYSA-N 2-amino-3,7-dihydropurin-6-one;3,7-dihydropurine-2,6-dione Chemical compound O=C1NC(N)=NC2=C1NC=N2.O=C1NC(=O)NC2=C1NC=N2 ZXXTYLFVENEGIP-UHFFFAOYSA-N 0.000 description 1
CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
102100027398 A disintegrin and metalloproteinase with thrombospondin motifs 1 Human genes 0.000 description 1
102100032635 A disintegrin and metalloproteinase with thrombospondin motifs 8 Human genes 0.000 description 1
108091005666 ADAMTS8 Proteins 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
208000010370 Adenoviridae Infections Diseases 0.000 description 1
206010060931 Adenovirus infection Diseases 0.000 description 1
102100027211 Albumin Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
102100038910 Alpha-enolase Human genes 0.000 description 1
101710165425 Alpha-enolase Proteins 0.000 description 1
102000009840 Angiopoietins Human genes 0.000 description 1
108010009906 Angiopoietins Proteins 0.000 description 1
102400000068 Angiostatin Human genes 0.000 description 1
108010079709 Angiostatins Proteins 0.000 description 1
108010064733 Angiotensins Proteins 0.000 description 1
102000015427 Angiotensins Human genes 0.000 description 1
108020004491 Antisense DNA Proteins 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
102000004411 Antithrombin III Human genes 0.000 description 1
108090000935 Antithrombin III Proteins 0.000 description 1
102000007592 Apolipoproteins Human genes 0.000 description 1
108010071619 Apolipoproteins Proteins 0.000 description 1
102000018616 Apolipoproteins B Human genes 0.000 description 1
108010027006 Apolipoproteins B Proteins 0.000 description 1
101100036901 Arabidopsis thaliana RPL40B gene Proteins 0.000 description 1
101000640990 Arabidopsis thaliana Tryptophan-tRNA ligase, chloroplastic/mitochondrial Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
102000005427 Asialoglycoprotein Receptor Human genes 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
241000271566 Aves Species 0.000 description 1
102100035526 B melanoma antigen 1 Human genes 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
102000015735 Beta-catenin Human genes 0.000 description 1
108060000903 Beta-catenin Proteins 0.000 description 1
206010004593 Bile duct cancer Diseases 0.000 description 1
206010005949 Bone cancer Diseases 0.000 description 1
208000018084 Bone neoplasm Diseases 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
101000583086 Bunodosoma granuliferum Delta-actitoxin-Bgr2b Proteins 0.000 description 1
102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 1
102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 1
101710098275 C-X-C motif chemokine 10 Proteins 0.000 description 1
102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 1
108700012434 CCL3 Proteins 0.000 description 1
108010046080 CD27 Ligand Proteins 0.000 description 1
108010017987 CD30 Ligand Proteins 0.000 description 1
108010041397 CD4 Antigens Proteins 0.000 description 1
108010029697 CD40 Ligand Proteins 0.000 description 1
101150013553 CD40 gene Proteins 0.000 description 1
102100032937 CD40 ligand Human genes 0.000 description 1
102100025221 CD70 antigen Human genes 0.000 description 1
101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 description 1
101100438971 Caenorhabditis elegans mat-1 gene Proteins 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
102100029968 Calreticulin Human genes 0.000 description 1
108090000549 Calreticulin Proteins 0.000 description 1
102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
102400000730 Canstatin Human genes 0.000 description 1
101800000626 Canstatin Proteins 0.000 description 1
241000710190 Cardiovirus Species 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108090000538 Caspase-8 Proteins 0.000 description 1
102100026548 Caspase-8 Human genes 0.000 description 1
102000011727 Caspases Human genes 0.000 description 1
108010076667 Caspases Proteins 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
102000000013 Chemokine CCL3 Human genes 0.000 description 1
101000709520 Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) Atypical response regulator protein ChxR Proteins 0.000 description 1
102100031186 Chromogranin-A Human genes 0.000 description 1
108010003384 Colony-Stimulating Factor Receptors Proteins 0.000 description 1
102000004626 Colony-Stimulating Factor Receptors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
108010035601 Coxsackie and Adenovirus Receptor Like Membrane Protein Proteins 0.000 description 1
102000008198 Coxsackie and Adenovirus Receptor Like Membrane Protein Human genes 0.000 description 1
108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
102000003849 Cytochrome P450 Human genes 0.000 description 1
102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
101100044298 Drosophila melanogaster fand gene Proteins 0.000 description 1
108010069091 Dystrophin Proteins 0.000 description 1
102000001039 Dystrophin Human genes 0.000 description 1
108010024212 E-Selectin Proteins 0.000 description 1
101150029662 E1 gene Proteins 0.000 description 1
101710175001 E1B protein, small T-antigen Proteins 0.000 description 1
101150005585 E3 gene Proteins 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
101150029707 ERBB2 gene Proteins 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 description 1
102100021451 Endoplasmic reticulum chaperone BiP Human genes 0.000 description 1
101710184673 Enolase 1 Proteins 0.000 description 1
241000709661 Enterovirus Species 0.000 description 1
101710204837 Envelope small membrane protein Proteins 0.000 description 1
208000000461 Esophageal Neoplasms Diseases 0.000 description 1
101710091919 Eukaryotic translation initiation factor 4G Proteins 0.000 description 1
101150064015 FAS gene Proteins 0.000 description 1
108091008794 FGF receptors Proteins 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 1
102400000921 Gastrin Human genes 0.000 description 1
102000004862 Gastrin releasing peptide Human genes 0.000 description 1
108090001053 Gastrin releasing peptide Proteins 0.000 description 1
108010052343 Gastrins Proteins 0.000 description 1
102000013382 Gelatinases Human genes 0.000 description 1
108010026132 Gelatinases Proteins 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
108050002220 Green fluorescent protein, GFP Proteins 0.000 description 1
208000012766 Growth delay Diseases 0.000 description 1
208000031220 Hemophilia Diseases 0.000 description 1
208000009292 Hemophilia A Diseases 0.000 description 1
229920000209 Hexadimethrine bromide Polymers 0.000 description 1
102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
102100032742 Histone-lysine N-methyltransferase SETD2 Human genes 0.000 description 1
208000017604 Hodgkin disease Diseases 0.000 description 1
208000021519 Hodgkin lymphoma Diseases 0.000 description 1
208000010747 Hodgkins lymphoma Diseases 0.000 description 1
101000936405 Homo sapiens A disintegrin and metalloproteinase with thrombospondin motifs 1 Proteins 0.000 description 1
101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 1
101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 1
101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 1
101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 1
101000654725 Homo sapiens Histone-lysine N-methyltransferase SETD2 Proteins 0.000 description 1
101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
101001005728 Homo sapiens Melanoma-associated antigen 1 Proteins 0.000 description 1
101001005717 Homo sapiens Melanoma-associated antigen 12 Proteins 0.000 description 1
101001005718 Homo sapiens Melanoma-associated antigen 2 Proteins 0.000 description 1
101001005719 Homo sapiens Melanoma-associated antigen 3 Proteins 0.000 description 1
101001057131 Homo sapiens Melanoma-associated antigen D4 Proteins 0.000 description 1
101000624947 Homo sapiens Nesprin-1 Proteins 0.000 description 1
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 1
101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
102100023915 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102100022338 Integrin alpha-M Human genes 0.000 description 1
108010008212 Integrin alpha4beta1 Proteins 0.000 description 1
102100026720 Interferon beta Human genes 0.000 description 1
102100037850 Interferon gamma Human genes 0.000 description 1
108010047761 Interferon-alpha Proteins 0.000 description 1
102000006992 Interferon-alpha Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
108090000177 Interleukin-11 Proteins 0.000 description 1
102000003815 Interleukin-11 Human genes 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
102000000646 Interleukin-3 Human genes 0.000 description 1
108090001007 Interleukin-8 Proteins 0.000 description 1
102000004890 Interleukin-8 Human genes 0.000 description 1
108010002335 Interleukin-9 Proteins 0.000 description 1
102000000585 Interleukin-9 Human genes 0.000 description 1
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
108090000769 Isomerases Proteins 0.000 description 1
102000004195 Isomerases Human genes 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
101150113776 LMP1 gene Proteins 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
102100026238 Lymphotoxin-alpha Human genes 0.000 description 1
108090000362 Lymphotoxin-beta Proteins 0.000 description 1
102100026894 Lymphotoxin-beta Human genes 0.000 description 1
102000043131 MHC class II family Human genes 0.000 description 1
108010000410 MSH receptor Proteins 0.000 description 1
241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
108010058398 Macrophage Colony-Stimulating Factor Receptor Proteins 0.000 description 1
101710175243 Major antigen Proteins 0.000 description 1
108010031099 Mannose Receptor Proteins 0.000 description 1
102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
102100025050 Melanoma-associated antigen 1 Human genes 0.000 description 1
102100025084 Melanoma-associated antigen 12 Human genes 0.000 description 1
102100025081 Melanoma-associated antigen 2 Human genes 0.000 description 1
102100025082 Melanoma-associated antigen 3 Human genes 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 description 1
108010050619 Monokines Proteins 0.000 description 1
102000013967 Monokines Human genes 0.000 description 1
108010063954 Mucins Proteins 0.000 description 1
206010048723 Multiple-drug resistance Diseases 0.000 description 1
101100335081 Mus musculus Flt3 gene Proteins 0.000 description 1
101000686934 Mus musculus Prolactin-7D1 Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
206010028570 Myelopathy Diseases 0.000 description 1
BKAYIFDRRZZKNF-VIFPVBQESA-N N-acetylcarnosine Chemical compound CC(=O)NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BKAYIFDRRZZKNF-VIFPVBQESA-N 0.000 description 1
102100023306 Nesprin-1 Human genes 0.000 description 1
102000004459 Nitroreductase Human genes 0.000 description 1
108010077850 Nuclear Localization Signals Proteins 0.000 description 1
108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 1
206010030155 Oesophageal carcinoma Diseases 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 description 1
108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
229930012538 Paclitaxel Natural products 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
208000030852 Parasitic disease Diseases 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000005877 Peptide Initiation Factors Human genes 0.000 description 1
108010044843 Peptide Initiation Factors Proteins 0.000 description 1
241000009328 Perro Species 0.000 description 1
102000009097 Phosphorylases Human genes 0.000 description 1
108010073135 Phosphorylases Proteins 0.000 description 1
241000709664 Picornaviridae Species 0.000 description 1
102100035846 Pigment epithelium-derived factor Human genes 0.000 description 1
108010001014 Plasminogen Activators Proteins 0.000 description 1
102000001938 Plasminogen Activators Human genes 0.000 description 1
108090000778 Platelet factor 4 Proteins 0.000 description 1
102100030304 Platelet factor 4 Human genes 0.000 description 1
208000002151 Pleural effusion Diseases 0.000 description 1
101100335198 Pneumocystis carinii fol1 gene Proteins 0.000 description 1
108010076039 Polyproteins Proteins 0.000 description 1
108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
102000003946 Prolactin Human genes 0.000 description 1
108010057464 Prolactin Proteins 0.000 description 1
102000007327 Protamines Human genes 0.000 description 1
108010007568 Protamines Proteins 0.000 description 1
102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
102000009572 RNA Polymerase II Human genes 0.000 description 1
108010009460 RNA Polymerase II Proteins 0.000 description 1
101100409194 Rattus norvegicus Ppargc1b gene Proteins 0.000 description 1
108090000783 Renin Proteins 0.000 description 1
102100028255 Renin Human genes 0.000 description 1
101710088839 Replication initiation protein Proteins 0.000 description 1
201000000582 Retinoblastoma Diseases 0.000 description 1
102000034527 Retinoid X Receptors Human genes 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
101100123443 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HAP4 gene Proteins 0.000 description 1
101100379247 Salmo trutta apoa1 gene Proteins 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
208000000453 Skin Neoplasms Diseases 0.000 description 1
102000039471 Small Nuclear RNA Human genes 0.000 description 1
108020004688 Small Nuclear RNA Proteins 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
208000021712 Soft tissue sarcoma Diseases 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
102400000096 Substance P Human genes 0.000 description 1
101800003906 Substance P Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
101000946719 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Carboxysome assembly protein CcmN Proteins 0.000 description 1
230000005867 T cell response Effects 0.000 description 1
102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 1
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
108700026226 TATA Box Proteins 0.000 description 1
102000006467 TATA-Box Binding Protein Human genes 0.000 description 1
108010044281 TATA-Box Binding Protein Proteins 0.000 description 1
102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 description 1
108700012411 TNFSF10 Proteins 0.000 description 1
102100032938 Telomerase reverse transcriptase Human genes 0.000 description 1
208000024313 Testicular Neoplasms Diseases 0.000 description 1
206010057644 Testis cancer Diseases 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
108060008245 Thrombospondin Proteins 0.000 description 1
102000002938 Thrombospondin Human genes 0.000 description 1
208000009453 Thyroid Nodule Diseases 0.000 description 1
208000024770 Thyroid neoplasm Diseases 0.000 description 1
102000006290 Transcription Factor TFIID Human genes 0.000 description 1
108010083268 Transcription Factor TFIID Proteins 0.000 description 1
102000007238 Transferrin Receptors Human genes 0.000 description 1
108010033576 Transferrin Receptors Proteins 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
102400001320 Transforming growth factor alpha Human genes 0.000 description 1
101800004564 Transforming growth factor alpha Proteins 0.000 description 1
102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
102100034300 Tryptophan-tRNA ligase, cytoplasmic Human genes 0.000 description 1
102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 1
102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
102400000731 Tumstatin Human genes 0.000 description 1
102000003425 Tyrosinase Human genes 0.000 description 1
108010046334 Urease Proteins 0.000 description 1
102100038851 Uroplakin-2 Human genes 0.000 description 1
101710173761 Uroplakin-2 Proteins 0.000 description 1
102100038854 Uroplakin-3a Human genes 0.000 description 1
108050004295 Uroplakin-3a Proteins 0.000 description 1
208000002495 Uterine Neoplasms Diseases 0.000 description 1
108091008605 VEGF receptors Proteins 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
208000008383 Wilms tumor Diseases 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
208000011589 adenoviridae infectious disease Diseases 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
230000032683 aging Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
102000015395 alpha 1-Antitrypsin Human genes 0.000 description 1
108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
NIGUVXFURDGQKZ-KRAHZTDDSA-N alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O NIGUVXFURDGQKZ-KRAHZTDDSA-N 0.000 description 1
229940030486 androgens Drugs 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000003302 anti-idiotype Effects 0.000 description 1
230000005809 anti-tumor immunity Effects 0.000 description 1
230000006023 anti-tumor response Effects 0.000 description 1
230000030741 antigen processing and presentation Effects 0.000 description 1
239000003816 antisense DNA Substances 0.000 description 1
229960005348 antithrombin iii Drugs 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
108010006523 asialoglycoprotein receptor Proteins 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
239000012131 assay buffer Substances 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000003385 bacteriostatic effect Effects 0.000 description 1
102000055102 bcl-2-Associated X Human genes 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
208000026900 bile duct neoplasm Diseases 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
238000001815 biotherapy Methods 0.000 description 1
201000000053 blastoma Diseases 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
239000000337 buffer salt Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
238000002619 cancer immunotherapy Methods 0.000 description 1
210000000234 capsid Anatomy 0.000 description 1
150000001720 carbohydrates Chemical group 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
210000005056 cell body Anatomy 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000022534 cell killing Effects 0.000 description 1
238000002659 cell therapy Methods 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
210000003679 cervix uteri Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
208000006990 cholangiocarcinoma Diseases 0.000 description 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
238000012761 co-transfection Methods 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000005138 cryopreservation Methods 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
108010045325 cyclic arginine-glycine-aspartic acid peptide Proteins 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
239000003145 cytotoxic factor Substances 0.000 description 1
238000002784 cytotoxicity assay Methods 0.000 description 1
231100000263 cytotoxicity test Toxicity 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
102000038379 digestive enzymes Human genes 0.000 description 1
108091007734 digestive enzymes Proteins 0.000 description 1
206010013023 diphtheria Diseases 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
229960004679 doxorubicin Drugs 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
201000008184 embryoma Diseases 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
210000004696 endometrium Anatomy 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
108060002566 ephrin Proteins 0.000 description 1
102000012803 ephrin Human genes 0.000 description 1
201000004101 esophageal cancer Diseases 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
108010052621 fas Receptor Proteins 0.000 description 1
102000018823 fas Receptor Human genes 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 description 1
238000001914 filtration Methods 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
238000002825 functional assay Methods 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
210000000232 gallbladder Anatomy 0.000 description 1
201000010175 gallbladder cancer Diseases 0.000 description 1
108010062699 gamma-Glutamyl Hydrolase Proteins 0.000 description 1
PUBCCFNQJQKCNC-XKNFJVFFSA-N gastrin-releasingpeptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C1=CNC=N1 PUBCCFNQJQKCNC-XKNFJVFFSA-N 0.000 description 1
238000012239 gene modification Methods 0.000 description 1
230000005017 genetic modification Effects 0.000 description 1
235000013617 genetically modified food Nutrition 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
108060003196 globin Proteins 0.000 description 1
102000018146 globin Human genes 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
235000004554 glutamine Nutrition 0.000 description 1
230000002414 glycolytic effect Effects 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
210000002443 helper t lymphocyte Anatomy 0.000 description 1
208000014951 hematologic disease Diseases 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
230000002390 hyperplastic effect Effects 0.000 description 1
210000001822 immobilized cell Anatomy 0.000 description 1
230000036737 immune function Effects 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
108010023260 immunoglobulin Fv Proteins 0.000 description 1
239000002955 immunomodulating agent Substances 0.000 description 1
229940121354 immunomodulator Drugs 0.000 description 1
230000004957 immunoregulator effect Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
238000009169 immunotherapy Methods 0.000 description 1
230000002637 immunotoxin Effects 0.000 description 1
239000002596 immunotoxin Substances 0.000 description 1
231100000608 immunotoxin Toxicity 0.000 description 1
229940051026 immunotoxin Drugs 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000036512 infertility Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
230000031700 light absorption Effects 0.000 description 1
210000005228 liver tissue Anatomy 0.000 description 1
238000003468 luciferase reporter gene assay Methods 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
230000035800 maturation Effects 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
206010061289 metastatic neoplasm Diseases 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
239000003607 modifier Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000006654 negative regulation of apoptotic process Effects 0.000 description 1
230000009826 neoplastic cell growth Effects 0.000 description 1
201000008026 nephroblastoma Diseases 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
108020001162 nitroreductase Proteins 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
229940023146 nucleic acid vaccine Drugs 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000007764 o/w emulsion Substances 0.000 description 1
238000005457 optimization Methods 0.000 description 1
229940126701 oral medication Drugs 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
229960005030 other vaccine in atc Drugs 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
229960001592 paclitaxel Drugs 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
244000045947 parasite Species 0.000 description 1
230000036281 parasite infection Effects 0.000 description 1
239000003182 parenteral nutrition solution Substances 0.000 description 1
239000013618 particulate matter Substances 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
238000012335 pathological evaluation Methods 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
238000002205 phenol-chloroform extraction Methods 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
108090000102 pigment epithelium-derived factor Proteins 0.000 description 1
230000033885 plasminogen activation Effects 0.000 description 1
229920001481 poly(stearyl methacrylate) Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
239000013641 positive control Substances 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
238000004321 preservation Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000000861 pro-apoptotic effect Effects 0.000 description 1
229940097325 prolactin Drugs 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
229950008679 protamine sulfate Drugs 0.000 description 1
235000019419 proteases Nutrition 0.000 description 1
108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
239000002213 purine nucleotide Substances 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
210000003370 receptor cell Anatomy 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000009711 regulatory function Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
239000000523 sample Substances 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
201000000849 skin cancer Diseases 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
239000001540 sodium lactate Substances 0.000 description 1
229940005581 sodium lactate Drugs 0.000 description 1
235000011088 sodium lactate Nutrition 0.000 description 1
229940054269 sodium pyruvate Drugs 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
210000003046 sporozoite Anatomy 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
108010057210 telomerase RNA Proteins 0.000 description 1
201000003120 testicular cancer Diseases 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
201000002510 thyroid cancer Diseases 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000005758 transcription activity Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
229940038237 tumor antigen vaccine Drugs 0.000 description 1
230000004565 tumor cell growth Effects 0.000 description 1
230000005851 tumor immunogenicity Effects 0.000 description 1
239000000225 tumor suppressor protein Substances 0.000 description 1
108010012374 type IV collagen alpha3 chain Proteins 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
210000003708 urethra Anatomy 0.000 description 1
206010046766 uterine cancer Diseases 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
239000004474 valine Substances 0.000 description 1
230000002227 vasoactive effect Effects 0.000 description 1
108010060757 vasostatin Proteins 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
230000035899 viability Effects 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
230000017613 viral reproduction Effects 0.000 description 1
239000007762 w/o emulsion Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1